Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Cord Blood to Cooperate with Singapore’s Cordlife

publication date: Jul 24, 2014
China Cord Blood of Hong Kong will cooperate with Singapore’s Cordlife Group to find suitable donors in each other’s umbilical cord blood stem cell banks. If a matching donor cannot be found in a company’s own facilities, the partner may be asked to search its registry. China Cord Blood owns licenses for Beijing, Guangdong Province and Zhejiang Province, while Cordlife has facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia. In 2012, Cordlife invested $20 million in China Cord Blood. More details....

Stock Symbols: (NYSE: CO) (SGX: CLGL)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital